Latest News
Cimarron Healthcare Capital Completes Acquisition of Infusion Management
Monday 16 September 2019

16 September 2019 - Salt Lake City, US-based Cimarron Healthcare Capital has completed a majority recapitalisation and growth equity raise with California, US-based Infusion Management, a management services organisation (MSO), the company said.
Financial terms of the transaction were not disclosed.
Infusion Management is the exclusive management services organisation (MSO) affiliated with Infusion for Health, a clinical provider of infusion therapy treatment for patients with multiple sclerosis, rheumatoid arthritis, and other autoimmune and immunodeficiency disorders in the greater Los Angeles area.
Infusion Management said it will now be in a position to leverage Cimarron's experience and capabilities to become a premier infusion therapy MSO servicing not only the greater Los Angeles market, but the entire West Coast.
Infusion Management is an infusion therapy MSO providing services to Infusion for Health, the premier provider of infusion treatment services to patients in the Los Angeles market.
Cimarron Healthcare Capital is focussed on healthcare investments in the lower middle-market.
Date Published: 16/09/2019
Target: Infusion Management/majority stake
Country: USA
Sector: Healthcare
Type: LBO
Status: Closed
Buyer: Cimarron Healthcare Capital
Terms of the deal were not disclosed